butylscopolammonium bromide has been researched along with glucagon-like peptide 1 in 1 studies
| Studies (butylscopolammonium bromide) | Trials (butylscopolammonium bromide) | Recent Studies (post-2010) (butylscopolammonium bromide) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
|---|---|---|---|---|---|
| 695 | 165 | 149 | 9,484 | 1,208 | 6,374 |
| Protein | Taxonomy | butylscopolammonium bromide (IC50) | glucagon-like peptide 1 (IC50) |
|---|---|---|---|
| Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaikomin, R; Doran, S; Holloway, RH; Horowitz, M; Jones, KL; Meyer, JH; Rayner, CK; Renooij, W; Smout, AJ; Wu, KL | 1 |
1 other study(ies) available for butylscopolammonium bromide and glucagon-like peptide 1
| Article | Year |
|---|---|
Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release.
Topics: 3-O-Methylglucose; Adult; Blood Glucose; Butylscopolammonium Bromide; Case-Control Studies; Duodenum; Electric Impedance; Gastric Inhibitory Polypeptide; Gastrointestinal Motility; Gastrointestinal Transit; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Intestinal Absorption; Male; Manometry; Muscarinic Antagonists; Peristalsis; Reference Values; Sensitivity and Specificity; Single-Blind Method; Time Factors | 2007 |